Conference Menu

Overview
Day 1
Day 2
Day 3
Short Course
Poster Information
Hotel & Travel
Contact us
Registration 


Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean

Corporate Sponsors:

DiscoverRx 

 

Promega BLACK

 

Corporate Support Sponsor:

ProQinase-Drug Discovery in Oncology


Media Partners:

Biospace
Drug Discovery News
Gen
Genomeweb Logo
Insight Pharma Reports
Nature

PharmaVoice
Science AAAS
SelectScience
The Scientist 

Catalog
Industry Event Calendar


Next-Gen Kinase Inhibitors 2013
17 June, 2013 - 19 June, 2013 The Revere Hotel 200 Stuart St., Boston, MA, USA


Next-Gen Kinase Inhibitors Conference - Cambridge Healthtech Institute



This established and well-recognized kinase conference addresses reoccurring questions about selectivity, safety, resistance and novelty. After many years of research and therapeutic developments of kinase inhibitors, the field still offers new opportunities as novel kinases and their inhibitors are making an appearance. In addition, interest in repurposing of already developed drugs is growing immensely.

“Next-Gen Kinase Inhibitors” addresses what lies ahead, what is in store for the pharmaceutical industry and what new avenues are opening up in regards to technologies and methods used, and in regards to novel targets and therapeutic approaches explored.

Day 1 | Day 2 | Day 3 


» 8:30 Keynote Presentation  

Doriano Fabbro, Ph.D., CSO, Piqur Therapeutics


TOPIC HIGHLIGHTS: 

  • Non-Cancer Indications
  • Designing Selective Inhibitors
  • Property-Based Design
 
  • Overcoming Resistance
  • Structure-Based Design
  • Screening and Validation
 

Monday, June 17 • 9:00 – 12:00 pm 


Short Course: The Art and Science of Kinases* 

Course Instructor: Kent D. Stewart, Ph.D., Research Fellow, Structural Biology, Abbvie


*Separate Registration Required

Global Information, Inc. - International Marketing Partner of CHI.